Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Detection of Dysbiosis and Increased Intestinal Permeability in Brazilian Patients with Relapsing–Remitting Multiple Sclerosis
Felipe Papa Pellizoni, Aline Zazeri Leite, Nathália Rodrigues, et al.
International Journal of Environmental Research and Public Health (2021) Vol. 18, Iss. 9, pp. 4621-4621
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

The intestinal barrier in disorders of the central nervous system
Carolina Pellegrini, Matteo Fornai, Vanessa D’Antongiovanni, et al.
˜The œLancet. Gastroenterology & hepatology (2022) Vol. 8, Iss. 1, pp. 66-80
Closed Access | Times Cited: 110
Changes in Gut Microbiota and Multiple Sclerosis: A Systematic Review
Alba Ordoñez-Rodriguez, Pablo Román, Lola Rueda‐Ruzafa, et al.
International Journal of Environmental Research and Public Health (2023) Vol. 20, Iss. 5, pp. 4624-4624
Open Access | Times Cited: 58
Role of Akkermansia in Human Diseases: From Causation to Therapeutic Properties
Antonio Pellegrino, Gaetano Coppola, Francesco Santopaolo, et al.
Nutrients (2023) Vol. 15, Iss. 8, pp. 1815-1815
Open Access | Times Cited: 42
Gut Dysbiosis and Fecal Microbiota Transplantation in Autoimmune Diseases
Paulína Belvončíková, Martin Marônek, Roman Gardlík
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 18, pp. 10729-10729
Open Access | Times Cited: 46
Food, gut barrier dysfunction, and related diseases: A new target for future individualized disease prevention and management
Linda Liang, Clarissa Saunders, Nerses Sanossian
Food Science & Nutrition (2023) Vol. 11, Iss. 4, pp. 1671-1704
Open Access | Times Cited: 31
Dietary Fat Modulation of Gut Microbiota and Impact on Regulatory Pathways Controlling Food Intake
Sevag Hamamah, Arman Amin, Abdul Latif Al-Kassir, et al.
Nutrients (2023) Vol. 15, Iss. 15, pp. 3365-3365
Open Access | Times Cited: 26
Zonulin as a Biomarker for the Development of Celiac Disease
Tracey M. DaFonte, Francesco Valitutti, Victoria Kenyon, et al.
PEDIATRICS (2023) Vol. 153, Iss. 1
Closed Access | Times Cited: 20
Identification of commensal gut microbiota signatures as predictors of clinical severity and disease progression in multiple sclerosis
Theresa L Montgomery, Qin Wang, Ali Mirza, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 7
Fecal Mucoprotein MUC2 is Decreased in Multiple Sclerosis and is Associated with Mucin Degrading Bacteria
Luke Schwerdtfeger, Federico Montini, Tanuja Chitnis, et al.
(2025)
Closed Access
Perturbations in gut microbiota composition in patients with autoimmune neurological diseases: a systematic review and meta-analysis
Xiaolin Deng, Xue Gong, Dong Zhou, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Microbiota-Driven Mechanisms in Multiple Sclerosis: Pathogenesis, Therapeutic Strategies, and Biomarker Potential
Mohammad Hossein Nemati, Esmaeil Yazdanpanah, Roya Kazemi, et al.
Biology (2025) Vol. 14, Iss. 4, pp. 435-435
Open Access
The second brain: The connection between gut microbiota composition and multiple sclerosis
Melina Farshbafnadi, Elmira Agah, Nima Rezaei
Journal of Neuroimmunology (2021) Vol. 360, pp. 577700-577700
Closed Access | Times Cited: 26
Microbial Metabolites in Multiple Sclerosis: Implications for Pathogenesis and Treatment
Eduardo Duarte-Silva, Sven G. Meuth, Christina Alves Peixoto
Frontiers in Neuroscience (2022) Vol. 16
Open Access | Times Cited: 10
Identification of commensal gut microbiota signatures as predictors of clinical severity and disease progression in multiple sclerosis
Theresa L Montgomery, Qin Wang, Ali Mirza, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 5
Oral vancomycin treatment suppresses gut trypsin activity and preserves intestinal barrier function during EAE
Paola Bianchimano, Kacper Iwanowski, Emma Smith, et al.
iScience (2023) Vol. 26, Iss. 11, pp. 108143-108143
Open Access | Times Cited: 4
In-silico characterization of GABAT protein found in gut-brain axis associated bacteria of healthy individuals and multiple sclerosis patients
Nadia Hussain, Fatima Muccee
Saudi Journal of Biological Sciences (2024) Vol. 31, Iss. 4, pp. 103939-103939
Open Access | Times Cited: 1
Mediterranean diet and associations with the gut microbiota and pediatric-onset multiple sclerosis using trivariate analysis
Ali Mirza, Feng Zhu, Natalie Knox, et al.
Communications Medicine (2024) Vol. 4, Iss. 1
Open Access | Times Cited: 1
New Perspectives in Health: Gut Microbiota
Diana Cardona, Pablo Román
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 10, pp. 5828-5828
Open Access | Times Cited: 6
Probiotic Influences on Motor Skills: A Review
Robert Lalonde, C. Strazielle
Current Neuropharmacology (2023) Vol. 21, Iss. 12, pp. 2481-2486
Open Access | Times Cited: 2
Bifidobacteria in disease: from head to toe
Weiliang Zhang, Qiang Jia, Mingming Han, et al.
Folia Microbiologica (2023) Vol. 69, Iss. 1, pp. 1-15
Closed Access | Times Cited: 2
Higher Bifidobacterium spp. fecal abundance is associated with a lower prevalence of hyperglycemia and cardiovascular risk markers among schoolchildren from Bahia, Brazil
Camilla Almeida Menezes, Dalila Lucíola Zanette, Letícia Bastos Magalhães, et al.
PLoS ONE (2023) Vol. 18, Iss. 10, pp. e0290813-e0290813
Open Access | Times Cited: 2
Role of the gut microbiome in multiple sclerosis: From etiology to therapeutics
Shailesh K. Shahi, Meeta Yadav, Sudeep Ghimire, et al.
International review of neurobiology (2022), pp. 185-215
Closed Access | Times Cited: 4
Role of the intestinal microbiota in the pathogenesis of multiple sclerosis. Part 1. Clinical and experimental evidence for the involvement of the gut microbiota in the development of multiple sclerosis
И. Н. Абдурасулова
Medical academic journal (2022) Vol. 2, Iss. 2, pp. 9-36
Closed Access | Times Cited: 4
Changes in gut microbiome taxonomic composition and their relationship to biosynthetic and metabolic pathways of B vitamins in children with multiple sclerosis
И. Н. Абдурасулова, Elena Chernyavskaya, Veronika Nikitina, et al.
Журнал эволюционной биохимии и физиологии (2024) Vol. 60, Iss. 1, pp. 114-134
Closed Access
Role of the intestinal microbiota in the pathogenesis of multiple sclerosis. Part 3. Gut microbiota as a potential trigger for multiple sclerosis
И. Н. Абдурасулова
Medical academic journal (2024) Vol. 24, Iss. 3, pp. 5-44
Closed Access
Page 1 - Next Page

Scroll to top